SLC12A3 and Gitelman syndrome: Although a lowered IC50 for TZD inhibition due to increased NDCBE expression following NCC knockout (Eladari and Chambrey, 2011) could occur, depending upon the presence of NDCBE spare transporters, a lowered IC50 does not appear to occur at least in Gitelman’s syndrome.